Skip to main content

Advertisement

Log in

Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

The new World Health Organization (WHO) classification of gastric cancer includes a histological subtype of poorly cohesive carcinoma (PCC), which includes signet-ring cell (SRC) phenotype. We aimed to examine the concordance between preoperative clinical and postoperative histological diagnoses according to the 2010 WHO histological subtypes and to compare the prognoses of these subtypes.

Methods

The study cohort comprised 665 patients who underwent gastrectomy from 2005 to 2019. Histological subtypes were classified into PCC-NOS (non-signet ring cell subtype), SRC, and non-PCC, which were defined by the predominant component in accordance with the 2010 WHO classification of gastric cancer. The concordance of clinical and pathological diagnosis was examined and clinicopathological characteristics and survival outcome of the three subtypes compared.

Results

The cancers of 443 patients (66.7%) were classified as non-PCC, of 112 patients (16.8%) as PCC-NOS, and of 110 patients (16.5%) as SRC predominant subtypes. Significant differences in sex, age, tumor location, size, macroscopic type, and pathological TNM category (all P<0.05) were found. The concordance rate of preoperative and postoperative histological subtypes was significantly lower for poorly cohesive than other subtypes (P<0.0001). Preoperative stage tended to be underestimated for PCC-NOS subtype and these patients had poorer overall survival than those with the other two subtypes (P=0.005). Multivariate logistic regression analysis of overall survival showed that WHO histological subtype (PCC-NOS vs. non-PCC/SRC, HR: 1.64, 95% CI: 1.18–2.29, P=0.0034) was a significant independent prognostic factor.

Conclusion

Our results suggest that poorly cohesive carcinoma subtypes have different biological characteristics and prognoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lauwers GY, Carneiro F, Graham DY et al (2010) WHO classification of tumours of the digestive system, 4th edn. IARC Press, Lyon, pp 48–58

    Google Scholar 

  2. Voron T, Messager M, Duhamel A et al (2016) Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer 19:1027–1040

    Article  CAS  Google Scholar 

  3. Robb WB, Messager M, Gronnier C et al (2015) High-grade toxicity to neoadjuvant treatment for upper gastrointestinal carcinomas: what is the impact on perioperative and oncologic outcomes? Ann Surg Oncol 22:3632–9

    Article  Google Scholar 

  4. Al-Batran SE, Hofheinz RD, Pauligk C et al (2016) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol 17:1697–1708

    Article  CAS  Google Scholar 

  5. Katai H, Ishikawa T, Akazawa K et al (2018) Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer 21:144–154

    Article  Google Scholar 

  6. Marrelli D, Pedrazzani C, Morgagni P et al (2011) Changing clinical and pathological features of gastric cancer over time. Br J Surg 98:1273–83

    Article  CAS  Google Scholar 

  7. Wu H, Rusiecki JA, Zhu K et al (2009) Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 18:1945–52

    Article  Google Scholar 

  8. Henson DE, Dittus C, Younes M et al (2004) Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973–2000: increase in the signet ring cell type. Arch Pathol Lab Med 128:765–70

    Article  Google Scholar 

  9. Kouzu K, Tsujimoto H, Hiraki S et al (2018) Diagnostic accuracy of T stage of gastric cancer from the view point of application of laparoscopic proximal gastrectomy. Mol Clin Oncol 8:773–778

    PubMed  PubMed Central  Google Scholar 

  10. Kim JH, Song KS, Youn YH et al (2007) Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc 66:901–8

    Article  Google Scholar 

  11. Jiang CG, Wang ZN, Sun Z et al (2011) Clinicopathologic characteristics and prognosis of signet ring cell carcinoma of the stomach: results from a Chinese mono-institutional study. J Surg Oncol 103:700–3

    Article  Google Scholar 

  12. Chon HJ, Hyung WJ, Kim C et al (2017) Differential prognostic implications of gastric signet ring cell carcinoma: stage adjusted analysis from a single high-volume center in Asia. Ann Surg 265:946–953

    Article  Google Scholar 

  13. Taghavi S, Jayarajan SN, Davey A et al (2012) Prognostic significance of signet ring gastric cancer. J Clin Oncol 30:3493–8

    Article  Google Scholar 

  14. Chiu CT, Kuo CJ, Yeh TS et al (2011) Early signet ring cell gastric cancer. Dig Dis Sci 56:1749–56

    Article  Google Scholar 

  15. Liu K, Wan J, Bei Y et al (2017) Prognostic impact of different histological types on gastric adenocarcinoma: a surveillance, epidemiology, and end results database analysis. Pathol Oncol Res 23:881–887

    Article  Google Scholar 

  16. Jouini R, Khanchel F, Sabbah M et al (2020) Prognostic significance of poorly cohesive gastric carcinoma in Tunisian patients. Heliyon 6:e03460.

  17. Japanese Gastric Cancer A. (2020) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer.

  18. Marriette C, Carneiro F, Grabsch HI et al (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer 22:1–9

    Article  Google Scholar 

  19. Kunisaki C, Akiyama H, Nomura M et al (2006) Clinicopathological properties of poorly-differentiated adenocarcinoma of the stomach: comparison of solid- and non-solid-types. Anticancer Res 26:639–46

    PubMed  Google Scholar 

  20. Fujimoto A, Ishikawa Y, Ishii T et al (2017) Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry. Pathol Int 67:398–403

    Article  CAS  Google Scholar 

  21. Terashima M, Yoshikawa T, Boku N et al (2020) Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives. Jpn J Clin Oncol 50:528–534

    Article  Google Scholar 

  22. Terashima M, Iwasaki Y, Mizusawa J et al (2019) Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer 22:1044–1052

    Article  CAS  Google Scholar 

  23. Zu H, Wang H, Li C et al (2014) Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer. Int J Clin Exp Pathol 7:5692–700

    PubMed  PubMed Central  Google Scholar 

  24. Kwon KJ, Shim KN, Song EM et al (2014) Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer 17:43–53

    Article  Google Scholar 

  25. Kang SH, Kim JS, Moon HS et al (2017) Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky? Medicine (Baltimore) 96:e7532.

  26. Kwon CH, Kim YK, Lee S et al (2018) Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognositic significance based on histopathological subtypes

Download references

Acknowledgment

We thank Dr Trish Reynolds, MBBS, FRACP, from Edanz Group (https://en-author-services.edanzgroup.com/) for editing a draft of this manuscript.

Funding

This study had no funding support.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by KN, KE, and SI. The first draft of the manuscript was written by KN and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kenichi Nakamura.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest.

Ethical standards

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, K., Eto, K., Iwagami, S. et al. Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer. Int J Clin Oncol 27, 512–519 (2022). https://doi.org/10.1007/s10147-021-02069-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-021-02069-6

Keywords

Navigation